Responsible Officer: Andrew Retfalvi | Registered Since 2024
Acadia is a biopharmaceutical company focused on the development and commercialization of treatments for people that need them most, including in Rett Syndrome.
Registration Number: CL3330-20240722032514
Region: Ontario
Address: 295 Robinson St. Suite 100, Oakville, ON, L6J 1G7, Canada